ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Short Interest Up 50.0% in September

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) was the target of a large increase in short interest during the month of September. As of September 15th, there was short interest totaling 7,200 shares, an increase of 50.0% from the August 31st total of 4,800 shares. Based on an average trading volume of 11,000 shares, the short-interest ratio is currently 0.7 days. Based on an average trading volume of 11,000 shares, the short-interest ratio is currently 0.7 days.

ProShares UltraShort Nasdaq Biotechnology Price Performance

Shares of NASDAQ BIS opened at $11.87 on Thursday. The business’s 50-day simple moving average is $14.05 and its 200-day simple moving average is $16.90. ProShares UltraShort Nasdaq Biotechnology has a 52 week low of $11.71 and a 52 week high of $25.87.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Wednesday, September 24th were issued a $0.1543 dividend. This is an increase from ProShares UltraShort Nasdaq Biotechnology’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Wednesday, September 24th. This represents a $0.62 dividend on an annualized basis and a yield of 5.2%.

ProShares UltraShort Nasdaq Biotechnology Company Profile

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.